These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1323916)
1. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)]. Tuba Z; Mahó S Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of 2 beta,16 beta-bis-(4'-dimethyl-1'-piperazino)-3 alpha,17 beta-diacetoxy-5 alpha-androstane dibromide and related compounds. Tuba Z Arzneimittelforschung; 1980; 30(2a):342-6. PubMed ID: 6248076 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopharmacology of Arduan]. Mészáros C Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacologic effects of pipecuronium bromide (Arduan)]. Kárpáti E; Bíró K Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of steroids. Part 44: Analytical investigation of the intermediates of the synthesis of pipecuronium bromide (Arduan)]. Laukó A; Horváth P; Trischler F; Görög S Acta Pharm Hung; 1992 May; 62(3):82-7. PubMed ID: 1323917 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide. Kárpáti E; Biró K Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921 [TBL] [Abstract][Full Text] [Related]
7. The effect of the steroid muscle relaxant pipecurium bromide on the acetylcholinesterase activity of red blood cells in vitro. Simon G; Biró K; Kárpáti E; Tuba Z Arzneimittelforschung; 1980; 30(2a):360-3. PubMed ID: 6248079 [TBL] [Abstract][Full Text] [Related]
8. On some properties of a new steroid curare-like compound pipecurium bromide. Alyautdin RN; Buyanov VV; Fisenko VP; Lemina EJ; Muratov VK; Samoilov DN; Shorr VA Arzneimittelforschung; 1980; 30(2a):355-7. PubMed ID: 6248077 [TBL] [Abstract][Full Text] [Related]
9. Clinical experiences with pipecuronium bromide. Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience with a new steroid muscle relaxant: pipecurium bromide. Bunjatjan AA; Miheev VI Arzneimittelforschung; 1980; 30(2a):383-5. PubMed ID: 6248085 [TBL] [Abstract][Full Text] [Related]
11. Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases. Barankay A Arzneimittelforschung; 1980; 30(2a):386-9. PubMed ID: 6248086 [TBL] [Abstract][Full Text] [Related]
12. Report on clinical test of pipecurium bromide. Wittek L; Gecsényi M; Barna B; Hargitay Z; Adorján K Arzneimittelforschung; 1980; 30(2a):379-83. PubMed ID: 6248084 [TBL] [Abstract][Full Text] [Related]
13. Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecurium bromide, in anaesthetized dogs. Pulay I; Alánt O; Darvas K; Weltner J; Zétény Z Arzneimittelforschung; 1980; 30(2a):358-60. PubMed ID: 6248078 [TBL] [Abstract][Full Text] [Related]
14. Observations on the neuromuscular blocking action of pipecuronium in the dog. Jones RS Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans. Tassonyi E; Szabó G; Vereczkey L Arzneimittelforschung; 1981; 31(10):1754-6. PubMed ID: 6274362 [TBL] [Abstract][Full Text] [Related]